ArticleFrontiers in oncology2026
Radiomics-machine learning model for predicting invasiveness of subcentimeter subsolid lung adenocarcinoma: a validation study with external cohort and SHAP interpretability.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative discrimination of invasive adenocarcinoma (IAC) from pre-invasive lesions in subcentimeter subsolid nodules (SSNs) remains challenging using conventional computed tomography (CT). We aimed to develop and validate an interpretable radiomics-machine learning (ML) model for predicting invasiveness by leveraging SHapley Additive exPlanations (SHAP). Methods: In this two-center retrospective study, 177 patients from Hospital 1 (training and internal validation) and 83 patients from Hospital 2 (independent external validation) with surgically confirmed lung adenocarcinoma manifesting as SSNs (≤1 cm) were enrolled. Radiomic features were then extracted from preoperative CT using the uAI Research Portal. Following a reproducibility assessment (intraclass correlation coefficient >0.75), the minimum Redundancy Maximum Relevance (mRMR) and Least Absolute Shrinkage and Selection Operator (LASSO) regression were applied to select the most predictive features. Three ML classifiers: logistic regression (LR), random forest (RF) and support vector machine (SVM) were trained and validated using a 7:3 cohort split, and the best-performing model was further evaluated in the external validation cohort. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, F1 score, calibration, and decision curve analysis (DCA). SHAP analysis was employed to provide global and local model interpretability. Results: A set of ten radiomic features was selected to predict invasiveness (IAC prevalence: 44.6%). The LR model demonstrated optimal performance during internal validation (AUC: 0.842; sensitivity: 79.2%; specificity: 73.3%; F1 score: 0.745) and exhibited superior generalizability compared to both the RF and SVM models. In the external validation cohort, the LR model maintained robust diagnostic performance, with an AUC of 0.778 (95%CI: 0.673-0.862), confirming its cross-institutional generalizability. The DCA and PRC curves further confirmed its clinical utility and stability across different institutions. SHAP analysis identified wavelet_HLL_glszm_LowGrayLevelZoneEmphasis (an indicator of necrosis), original_shape_Flatness (reflecting morphological irregularity), and log_firstorder_LoG.Minimum (suggestive of air-trapping) as top predictors of invasiveness. Decision curve analysis confirmed the model's superior clinical utility over empirical management strategies. Conclusion: The developed radiomics-LR model robustly predicts invasiveness in subcentimeter SSNs and provides biologically plausible explanations through SHAP. Its balanced performance and inherent interpretability support its potential integration into clinical workflow to aid in surgical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.